Increased cellular expression of Tim-3 and an inverse correlation of Tim-3 expression with cancer prognosis have been reported in various cancers including hepatocellular carcinoma, B cell lymphoma, and pancreatic cancer [9,10,11]. This evidence concerns the gene HAVCR2 and B-cell non-Hodgkin lymphoma.